Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S8 pseudogene 11 is a processed pseudogene of the RPS8 gene, which encodes a protein that is an integral component of the small 40S ribosomal subunit, essential for cellular protein synthesis[1][3]. However, RPS8P11 itself is a non-coding DNA sequence with no evidence of expression as protein or functional RNA, no defined biological function, and no direct therapeutic or disease relevance.[1][3] In summary, RPS8P11 is not recognized as a valid, functional molecular target in research or drug development. The functional parent gene, RPS8 (Ribosomal protein S8), encodes a component of the ribosome but its pseudogenes, including RPS8P11, do not contribute directly to cellular function, disease mechanisms, or drug responsiveness, and therefore should not be used as molecular targets in structured biological or medical information[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S8 pseudogene 11 (RPS8P11).